![Kathleen LaPorte](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kathleen LaPorte
Director/Board Member at
PRECIPIO, INC.
Net worth: 245 223 $ as of 2026-07-30
Profile
Kathleen D.
LaPorte was the founder of New Leaf Venture Partners LLC, founded in 2005, where the title held was Partner.
Ms. LaPorte is also the founder of HealthTech Capital Co...
Ms. LaPorte currently serves as Director at Aesthetic Sciences Corp.
and Precipio Diagnostics LLC.
Other current roles include Independent Director at Bolt Biotherapeutics, Inc. (since 2020), Precipio, Inc. (since 2018), CERo Therapeutics Holdings, Inc. (since 2021), and Q32 Bio, Inc. (since 2024).
Director positions are held at Elysium Therapeutics, Inc. (since 2016), Q32 Bio Operations, Inc. (since 2021), and D2G Oncology, Inc. (since 2020).
Former roles included Chief Executive Officer at Nodality, Inc. (2015–2016), Director at Cytyc Prenatal Products Corp., Onyx Pharmaceuticals, Inc., ISTA Pharmaceuticals, Inc. (2002–2011), VNUS Medical Technologies, Inc. (1997–2008), Transcept Pharmaceuticals, Inc. (Old) (2009), eHealth, Inc., Affymax, Inc. (2011–2013), Cellgate, Inc., Prometheus Laboratories, Inc., eHealthInsurance Services, Inc. (2000–2007), California Institute for Regenerative Medicine (2014–2017), Pearl Therapeutics, Inc., Transcept Pharma, Inc. (2011–2012), Phoenix Biotech Acquisition Corp.
(2021–2024), 89bio, Inc. (2021–2025), First Boston Corp.
(Analyst), Sprout Group (1993–2004), Asset Management Co. (1987–1992), New Leaf Venture Partners LLC (2005–2011), Credit Suisse Securities (USA) LLC (2005), and Western Association of Venture Capitalists (President).
Education includes an undergraduate degree from Yale University conferred in 1983 and an MBA from Stanford Graduate School of Business conferred in 1987.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
PRECIPIO, INC. 0.41% | 2026-01-14 | 7,382 ( 0.41% ) | 159 820 $ | 2026-07-30 |
0.02% | 2026-06-11 | 5,431 ( 0.02% ) | 85 158 $ | 2026-07-30 |
| 2026-06-09 | 60 ( 0% ) | 239 $ | 2026-07-30 | |
0% | 2026-04-27 | 486 ( 0% ) | 5 $ | 2026-07-30 |
Kathleen LaPorte active positions
| Companies | Position | Start |
|---|---|---|
| PRECIPIO, INC. | Director/Board Member | 2018-08-08 |
| BOLT BIOTHERAPEUTICS, INC. | Director/Board Member | 2020-11-30 |
Elysium Therapeutics, Inc.
 Elysium Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development in biotechnology | Director/Board Member | 2016-07-31 |
D2G Oncology, Inc.
 D2G Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs for transform precision cancer therapeutics | Director/Board Member | 2019-12-31 |
Q32 Bio, Inc.
 Q32 Bio, Inc. BiotechnologyHealth Technology Develops immunomodulatory therapies with protein based molecules using a platform | Director/Board Member | 2021-08-02 |
Precipio Diagnostics LLC
 Precipio Diagnostics LLC Medical/Nursing ServicesHealth Services Operates as a cancer diagnostics reference laboratory | Director/Board Member | - |
Aesthetic Sciences Corp.
 Aesthetic Sciences Corp. Pharmaceuticals: MajorHealth Technology Provides aesthetic medicine and incontinence products | Director/Board Member | - |
Former positions of Kathleen LaPorte
| Companies | Position | End |
|---|---|---|
| 89BIO, INC. | Director/Board Member | 2025-10-29 |
Phoenix Biotech Acquisition Corp.
 Phoenix Biotech Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Director/Board Member | 2024-01-31 |
| ░░░░░░░░░░ ░░░░░░░░░ ░░░ ░░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Kathleen LaPorte
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
79
1st degree connections
32
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 32 |
|---|---|
First Boston Corp.
 First Boston Corp. Real Estate Investment TrustsFinance Operates as real estate investment trusts | Finance |
Cytyc Prenatal Products Corp.
 Cytyc Prenatal Products Corp. Medical SpecialtiesHealth Technology Provides products for the diagnosis of pregnancy related and female reproductive disorders | Health Technology |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
ISTA Pharmaceuticals, Inc.
 ISTA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets ophthalmic pharmaceutical products | Health Technology |
VNUS Medical Technologies, Inc.
 VNUS Medical Technologies, Inc. Medical SpecialtiesHealth Technology Provides medical devices for treatment of venous disease | Health Technology |
Transcept Pharmaceuticals, Inc. (Old)
 Transcept Pharmaceuticals, Inc. (Old) Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Aesthetic Sciences Corp.
Aesthetic Sciences Corp. Pharmaceuticals: MajorHealth Technology Provides aesthetic medicine and incontinence products | Health Technology |
eHealth, Inc.
 eHealth, Inc. Insurance Brokers/ServicesFinance Operates as an insurance agency that provides health and Medicare insurance services through online platform | Finance |
Nodality, Inc.
 Nodality, Inc. BiotechnologyHealth Technology Develops bioinformatics tools to enhance drug development process | Health Technology |
Precipio Diagnostics LLC
Precipio Diagnostics LLC Medical/Nursing ServicesHealth Services Operates as a cancer diagnostics reference laboratory | Health Services |
Sprout Group
 Sprout Group Investment ManagersFinance Sprout invest in companies located in North America. The firm focuses communications, software, services & e-commerce and healthcare technology sectors. | Finance |
Affymax, Inc.
 Affymax, Inc. BiotechnologyHealth Technology Develops and distributes pharmaceutical products | Health Technology |
Cellgate, Inc.
 Cellgate, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals products | Health Technology |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Asset Management Co.
 Asset Management Co. Investment ManagersFinance Alternative investment manager | Finance |
Prometheus Laboratories, Inc.
 Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel pharmaceutical and diagnostic products | Health Technology |
eHealthInsurance Services, Inc.
 eHealthInsurance Services, Inc. Life/Health InsuranceFinance Provides online health insurance plan services | Finance |
New Leaf Venture Partners LLC
 New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Ventures invests in public and private healthcare technology companies located in the US. The firm participates in early and later-stage capital requirements. | Finance |
Credit Suisse Securities (USA) LLC
 Credit Suisse Securities (USA) LLC Regional BanksFinance Provides investment banking, asset management and securities brokerage services | Finance |
California Institute for Regenerative Medicine
 California Institute for Regenerative Medicine General GovernmentGovernment Provides medical services | Government |
Western Association of Venture Capitalists | |
Pearl Therapeutics, Inc.
 Pearl Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for the treatment of chronic respiratory diseases | Health Technology |
Transcept Pharma, Inc.
 Transcept Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
HealthTech Capital Co.
 HealthTech Capital Co. Investment ManagersFinance HealthTech Capital Co invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for seed and early stage capital requirements. It makes an follow on investments. | Finance |
Stanford Graduate School of Business
 Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bolt Biotherapeutics, Inc.
 Bolt Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company | Health Technology |
Precipio, Inc.
 Precipio, Inc. Medical/Nursing ServicesHealth Services Provides medical diagnostics services | Health Services |
Elysium Therapeutics, Inc.
Elysium Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
89bio, Inc.
 89bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Develops immunomodulatory therapies with protein based molecules using a platform | Health Technology |
D2G Oncology, Inc.
D2G Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs for transform precision cancer therapeutics | Health Technology |
Phoenix Biotech Acquisition Corp.
Phoenix Biotech Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
- Stock Market
- Insiders
- Kathleen LaPorte
